Protein Summary
Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes with multiple subunits, each possessing transmembrane regions, and all arranged to form a ligand-gated ion channel. The classification of glutamate re ...more
- ENST00000285900
- ENSP00000285900
- ENSG00000155511
- ENST00000340592
- ENSP00000339343
- ENST00000448073
- ENSP00000415569
- ENST00000518142
- ENSP00000427920
- ENST00000518783
- ENSP00000428994
- ENST00000521843
- ENSP00000427864
- GLUH1
- GLUR1
- GLUH1
- GLUR1
- GLURA
- GluA1
- HBGR1
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
molecular function | 0.9 | ||
hub protein | 0.88 | ||
biological term | 0.81 | ||
kinase | 0.8 | ||
trait | 0.75 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 2316.81 (req: < 5)
Gene RIFs: 68 (req: <= 3)
Antibodies: 932 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 2316.81 (req: >= 5)
Gene RIFs: 68 (req: > 3)
Antibodies: 932 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 13
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 73
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drugs: 6